Clinical Trials Directory

Trials / Completed

CompletedNCT01648244

The Use of a Computer Program to Help Primary Care Providers Treat Patients With Type 2 Diabetes

The Use of a Computer Assisted Diabetes Decision Support (CADS) System to Improve Outcomes in Patients With Type 2 Diabetes Who Are Treated by Primary Care Providers

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
28 (actual)
Sponsor
Walter Reed National Military Medical Center · Federal
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The primary purpose of this study is to determine whether the use of CADS by primary care providers (PCPs) for their patients with type 2 diabetes (T2DM) changes the quality of care relative to a "usual care" group in terms of objective outcome measures of glycemic control (e.g., A1c, mean blood glucose, frequency of hypoglycemic episodes) and in terms of subjective ratings by patients.

Detailed description

The CADS software integrates the patient's home blood glucose data with appropriate laboratory data (e.g. A1c, liver function, kidney function), demographic data (age, gender), current and previous medications, and active/inactive medical diagnoses. The software makes a recommendation about what medication changes are appropriate with potential alternates. Providers with their patients are block randomized into CADS or "Usual Care" for 1 year.

Conditions

Interventions

TypeNameDescription
OTHERComputer-Assisted Decision SupportThe CADS software makes a recommendation about what medication changes are appropriate with potential alternates. CADS providers will either "accept" or "reject" the recommendation by the software.Providers with their patients are block randomized into CADS or "Usual Care" for 1 year. Patients associated with a CADS provider will upload their blood glucose data weekly and perform a 7-point glucose profile once per month. They will report major hypoglycemic events and hospitalizations at the time of their quarterly visit. Those getting "usual care" will be seen quarterly and will do self-monitoring of blood glucose and have A1c tests as determined by the provider but no less than twice a year.

Timeline

Start date
2012-03-01
Primary completion
2015-03-01
Completion
2015-03-01
First posted
2012-07-24
Last updated
2015-11-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01648244. Inclusion in this directory is not an endorsement.